UCAR a penny China stock now at bottom 300X upside LONG
Updated
UCAR, a NASDAQ penny stock and a Chinese auto dealership enterprise is experiencing a huge
relative volume spike. UCAR had a great week in very active trading.
Now priced at about 0.07 per share, my near term target is 1.58
representing a consolidation pivot on the chart.
The all time high is the is 300X upside more or less. This is a risky play. It could get delisted
although NASDAQ will give it some more quarterly reports to make a case for regulatory
compliance and stock price stability I will take a small position here given the
risk. Warren Buffet got in on the cheap with BYD over the counter, he has been massively
rewarded for his very large position. Retail traders can make good profits with undervalued
penny stocks. I think that this right now is one of them. I will use a zig zag strategy
to take profits at high pivots and add into the position at low pivots along the way.
relative volume spike. UCAR had a great week in very active trading.
Now priced at about 0.07 per share, my near term target is 1.58
representing a consolidation pivot on the chart.
The all time high is the is 300X upside more or less. This is a risky play. It could get delisted
although NASDAQ will give it some more quarterly reports to make a case for regulatory
compliance and stock price stability I will take a small position here given the
risk. Warren Buffet got in on the cheap with BYD over the counter, he has been massively
rewarded for his very large position. Retail traders can make good profits with undervalued
penny stocks. I think that this right now is one of them. I will use a zig zag strategy
to take profits at high pivots and add into the position at low pivots along the way.
Trade active
Zoomed to 3 minutes time frame - Thursday was the pivot bottom for the week,Friday showed 14% gain from the pivot
Trade active
10R Tick Chart shows the overnight trade from the pivot an excellent 38% returnNote
Stock Pattern on Zoom- Symmetrical Triangle
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.